InsidersTradesSigma
Follow the 딥노이드 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 딥노이드 has published 7 insider filings. Market capitalisation: €48bn. The latest transaction was disclosed on 3 July 2026 (Sale). Among the most active insiders: 김태규. All data is free.
5
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
3 ops.
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,422 of 29,065 companies
27.5
score / 100
Value12
Quality43
FCF yld-14%
Earn yld-21%
EV/EBITDA·
ROE-55%
Gross mgn64%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 3 July 2026
About 딥노이드
Deepnoid is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions to enhance healthcare.